Discovery of curcumin, a component of golden spice, and its miraculous biological activities

Clinical and Experimental Pharmacology and Physiology - Tập 39 Số 3 - Trang 283-299 - 2012
Subash C. Gupta1, Sridevi Patchva2, Wonil Koh2, Bharat B. Aggarwal3
1Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
2Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
3Experimental Therapeutics

Tóm tắt

Summary1. Curcumin is the active ingredient of the dietary spice turmeric and has been consumed for medicinal purposes for thousands of years. Modern science has shown that curcumin modulates various signalling molecules, including inflammatory molecules, transcription factors, enzymes, protein kinases, protein reductases, carrier proteins, cell survival proteins, drug resistance proteins, adhesion molecules, growth factors, receptors, cell cycle regulatory proteins, chemokines, DNA, RNA and metal ions.2. Because of this polyphenol’s potential to modulate multiple signalling molecules, it has been reported to possess pleiotropic activities. First demonstrated to have antibacterial activity in 1949, curcumin has since been shown to have anti‐inflammatory, anti‐oxidant, pro‐apoptotic, chemopreventive, chemotherapeutic, antiproliferative, wound healing, antinociceptive, antiparasitic and antimalarial properties as well. Animal studies have suggested that curcumin may be active against a wide range of human diseases, including diabetes, obesity, neurological and psychiatric disorders and cancer, as well as chronic illnesses affecting the eyes, lungs, liver, kidneys and gastrointestinal and cardiovascular systems.3. Although many clinical trials evaluating the safety and efficacy of curcumin against human ailments have already been completed, others are still ongoing. Moreover, curcumin is used as a supplement in several countries, including India, Japan, the US, Thailand, China, Korea, Turkey, South Africa, Nepal and Pakistan. Although inexpensive, apparently well tolerated and potentially active, curcumin has not been approved for the treatment of any human disease.4. In the present article, we discuss the discovery and key biological activities of curcumin, with a particular emphasis on its activities at the molecular and cellular levels, as well as in animals and humans.

Từ khóa


Tài liệu tham khảo

Vogel, Pelletier J, 1815, Examen chimique de la racine de Curcuma, J. Pharm., 289

Vogel A, 1842, J. Pharm. Chem., 3, 20

Ivanow‐Gajewsky1870;3:624.

Ivanow‐Gajewsky P, 1872, Ber. Dtsch. Chem. Ges., 5, 1103

10.1002/cber.187000301196

10.1002/cber.191004302168

10.1002/cber.191304602149

10.1111/j.2042-7158.1953.tb14007.x

10.1038/164456a0

Patil TN, 1971, Hypocholesteremic effect of curcumin in induced hypercholesteremic rats, Indian J. Exp. Biol., 9, 167

Srinivasan M, 1972, Effect of curcumin on blood sugar as seen in a diabetic subject, Indian J. Med. Sci., 26, 269

10.1111/j.2042-7158.1973.tb09131.x

10.1016/0006-2952(76)90421-4

10.1016/0304-3835(85)90159-4

Singh S, 1995, Activation of transcription factor NF‐kappa B is suppressed by curcumin (diferuloylmethane) [published erratum appears in J. Biol. Chem. 1995; 270: 30 235], J. Biol. Chem., 270, 24995

10.1021/mp700113r

10.1055/s-2006-957450

10.1016/j.ijpharm.2006.12.043

10.1002/cncr.21300

10.1016/j.fct.2007.02.002

10.1016/j.jpba.2005.09.032

10.1080/07357900701209053

10.1158/1535-7163.MCT-06-0174

10.1007/s10555-010-9235-2

10.1016/j.canlet.2008.03.009

10.1016/j.bcp.2007.08.016

10.1007/978-0-387-46401-5_10

10.1017/S0007114509993667

10.1039/c1np00051a

10.1007/978-0-387-46401-5_4

Lev‐Ari S, 2006, Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down‐regulation of COX‐2 and EGFR and inhibition of Erk1/2 activity, Anticancer Res., 26, 4423

10.1124/mol.106.033167

10.1124/mol.105.017400

10.1258/ebm.2011.011028

10.1007/s10875-006-9066-7

10.1073/pnas.88.12.5292

10.1006/phrs.1998.0404

10.4049/jimmunol.171.7.3863

10.1007/BF01965935

10.1016/S0223-5234(97)89084-8

10.1016/j.bcp.2008.08.008

10.1016/j.freeradbiomed.2003.12.018

10.1016/S0891-5849(03)00325-3

10.1248/bpb.28.1438

10.1016/j.freeradbiomed.2005.09.008

10.1016/0167-4889(94)90198-8

10.1196/annals.1397.048

Reddy AC, 1992, Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes, Mol. Cell. Biochem., 111, 117

10.1016/j.canlet.2004.09.041

10.1080/01635581.2010.509835

10.1002/ijc.23097

10.1111/j.1471-4159.2007.04633.x

10.1158/0008-5472.CAN-06-3066

10.1124/mol.107.043554

10.1016/j.otohns.2004.09.006

Teiten MH, 2011, Anti‐proliferative potential of curcumin in androgen‐dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway, Int. J. Oncol., 38, 603

10.1093/carcin/bgr032

10.1677/ERC-09-0129

Chen JW, 2011, [Anti‐proliferative and anti‐metastatic effects of curcumin on oral cancer cells], Hua Xi Kou Qiang Yi Xue Za Zhi, 29, 83

10.1016/j.fertnstert.2008.03.045

10.1111/j.1751-1097.2011.00937.x

10.1139/W10-117

10.1177/1934578X1000501220

10.1128/JVI.02028-06

10.1111/j.1567-1364.2010.00637.x

10.1007/s10522-011-9326-7

10.1177/0022034509356169

10.1248/bpb.21.643

10.1007/s00436-008-1311-y

10.1016/j.bmcl.2009.03.060

10.1248/cpb.41.1640

10.1016/j.biocel.2008.06.010

10.1016/j.tips.2008.11.002

10.1111/j.1365-2672.2009.04225.x

10.1152/ajpgi.00449.2002

10.1038/sj.bjp.0705241

10.1081/IPH-120020471

Sawatpanich T, 2010, Effect of curcumin on vascular endothelial growth factor expression in diabetic mice kidney induced by streptozotocin, J. Med. Assoc. Thai., 93, S1

10.1016/j.fct.2011.02.004

10.1002/mnfr.200700184

10.3945/jn.108.100966

10.1111/j.1471-4159.2007.04613.x

10.1074/jbc.M404751200

10.1007/s11010-010-0563-x

10.1002/ana.10795

10.1089/rej.2009.0908

10.1016/j.freeradbiomed.2007.11.011

10.1007/s10787-007-1614-0

10.1016/j.lfs.2010.09.006

Gupta YK, 2009, Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats, Indian J. Physiol. Pharmacol., 53, 39

10.1016/j.ejphar.2007.08.001

10.1016/j.bcp.2005.04.041

10.3171/2011.2.JNS10784

10.5505/tjtes.2011.31391

10.1016/j.exppara.2010.01.005

10.1002/ptr.2551

10.1007/s11064-007-9547-y

10.1093/carcin/14.11.2219

10.1093/carcin/19.1.81

10.1111/j.1349-7006.2000.tb01031.x

10.1016/S0304-3835(98)00326-7

10.1016/j.bbadis.2004.09.006

Ikezaki S, 2001, Chemopreventive effects of curcumin on glandular stomach carcinogenesis induced by N‐methyl‐N′‐nitro‐N‐nitrosoguanidine and sodium chloride in rats, Anticancer Res., 21, 3407

10.1016/S0278-6915(00)00101-0

10.1002/ijc.2910510313

10.1093/carcin/19.9.1697

10.1016/S0022-5347(05)65819-3

10.1016/S0304-3835(97)00187-0

Huang MT, 1994, Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice, Cancer Res., 54, 5841

10.1080/01635580802416703

10.1016/j.brainres.2009.01.066

10.1002/ijc.24336

10.1002/ijc.25656

10.1002/ijc.20160

10.1002/pros.1074

10.1158/0008-5472.CAN-06-4257

10.1158/1535-7163.MCT-06-0556

Yoysungnoen P, 2005, Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice, Clin. Hemorheol. Microcirc., 33, 127

10.1158/1078-0432.CCR-05-1192

10.1158/1078-0432.CCR-06-3072

10.1016/j.canlet.2008.01.041

10.1007/s00213-008-1300-y

10.1016/j.pbb.2005.08.009

10.1016/j.imbio.2008.04.003

10.1152/ajpregu.00858.2006

10.1016/j.brainres.2008.01.104

10.1016/j.ejphar.2006.03.006

10.1016/S1043-6618(02)00283-9

10.1021/jf063446t

10.1093/jn/131.8.2090

10.1080/08860220701540326

10.1016/j.lfs.2006.06.001

10.1177/030089168707300105

10.1158/1078-0432.CCR-08-0024

10.1080/01635581.2010.513802

10.1007/s00280-010-1470-2

10.3109/07357907.2010.550592

Alwi I, 2008, The effect of curcumin on lipid level in patients with acute coronary syndrome, Acta Med. Indones., 40, 201

10.2165/00126839-200809040-00004

Allegri P, 2010, Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long‐term follow‐up, Clin. Ophthalmol., 4, 1201

Durgaprasad S, 2005, A pilot study of the antioxidant effect of curcumin in tropical pancreatitis, Indian J. Med. Res., 122, 315

10.1002/ajh.20757

10.1158/1535-7163.MCT-06-0545

10.1016/j.bcp.2005.04.043

10.1002/ijc.22645

10.1159/000099202

10.1111/j.1582-4934.2009.00711.x

10.1158/1535-7163.MCT-05-0493

10.1152/ajpgi.90428.2008

10.1080/07357900802653472

10.3109/09537104.2010.547637

10.1196/annals.1397.039

10.1631/jzus.B0820238

10.1593/tlo.09235

10.1186/1479-5876-9-71

10.1186/1471-2407-11-144

10.1007/s10637-007-9099-7

10.1590/S1677-55382009000300012

10.1038/sj.onc.1201941

Manikandan R, 2011, Effect of curcumin on the modulation of alphaA‐ and alphaB‐crystallin and heat shock protein 70 in selenium‐induced cataractogenesis in Wistar rat pups, Mol. Vis., 17, 388

10.1089/jop.2010.0123

10.3109/02713680903528345

10.1016/j.jss.2010.12.002

10.1093/carcin/bgp229

10.1152/ajplung.90443.2008

10.1016/j.fitote.2011.04.003

10.1016/j.ijpara.2010.12.011

Jia SH, 2010, [Protective effects of curcumin on neonatal rats with necrotizing enterocolitis], Zhongguo Dang Dai Er Ke Za Zhi, 12, 132

10.1016/S0895-3988(10)60006-2

10.1128/AAC.01242-08

10.1016/j.ejphar.2010.04.018

10.1111/j.1440-1746.2006.04777.x

10.1126/science.1093941

10.1152/ajprenal.00419.2010

10.1097/00007890-199807270-00001

10.1007/s00210-011-0624-z

10.1111/j.1745-7254.2008.00783.x

10.1016/j.jss.2004.11.009

10.1097/BCR.0b013e318203337b

10.1046/j.1524-475X.1998.60211.x

10.12968/jowc.2004.13.3.26589

10.1016/j.arcmed.2011.01.011

Zhang Y, 2011, Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis, Int. J. Mol. Med., 27, 87

10.1002/jat.1517

10.2478/v10042-008-0031-6

10.1080/10286020.2010.544253

10.1177/0968051907078605

10.1089/rej.2010.1031

10.1016/j.lfs.2009.03.013

10.1097/WNR.0b013e328314decb

10.1017/S0007114509345250